First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database

被引：0
|
作者：
Kenneth L. McCall
Bennett J. Doughty
Brian J. Piper
Heeral Naik
Seraphine Bange
Emily E. Leppien
机构：
[1] Binghamton University,Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences
[2] Geisinger Commonwealth School of Medicine,Department of Medical Education
[3] Geisinger Center for Pharmacy Innovation and Outcomes,School of Pharmacy and Pharmaceutical Sciences
[4] Binghamton University,Department of Mathematics and Statistics
[5] Binghamton University,undefined
来源：
International Journal of Clinical Pharmacy | 2024年 / 46卷
关键词：
Antipsychotics; Adverse drug events; Pharmacovigilance; Pharmacoepidemiology;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：515 / 521
页数：6
相关论文
共 50 条
  • [41] Identification of Cardiovascular Adverse Effects Associated With Midostaurin - A WHO Pharmacovigilance Database Analysis
    Choudhary, Arrush
    Manouchehri, Ali
    Moslehi, Javid
    Salem, Joe-elie
    CIRCULATION, 2020, 142
  • [42] Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
    Tong, Lihua
    Yuan, Yanling
    He, Wanming
    Yang, Wen
    Pan, Xingxi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [43] Sexual dysfunctions associated with antipsychotic drug intake: a retrospective analysis of the FDA adverse events reporting system (FAERS)
    Engel, Johanna
    Jeridi, Lamin
    Auerbach, Lilly
    Zolk, Oliver
    Greiner, Timo
    Heinze, Martin
    Buspavanich, Pichit
    Schneider, Michael
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [44] Serious Adverse Reactions of Bupropion for Smoking Cessation Analysis of the French Pharmacovigilance Database from 2001 to 2004
    Beyens, Marie-Noeelle
    Guy, Claire
    Mounier, Genevieve
    Laporte, Sylvie
    Ollagnier, Michel
    DRUG SAFETY, 2008, 31 (11) : 1017 - 1026
  • [45] Adverse events associated with tezepelumab: a safety analysis of clinical trials and a pharmacovigilance system
    Mao, Zhenyu
    Huang, Yuchen
    Zhu, Xiaoyan
    Zheng, Pengdou
    Wang, Lingling
    Zhang, Fengqin
    Liu, Wei
    Liu, Huiguo
    Liao, Wenhui
    Zhou, Ling
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [46] Hepatitis-related adverse events associated with immune checkpoint inhibitors in cancer patients: an observational, retrospective, pharmacovigilance study using the FAERS database
    Fu, Zhiwen
    Liu, Jinmei
    Zhang, Cong
    Hu, Huiping
    Li, Shijun
    Zhang, Yu
    You, Ruxu
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [47] Adverse Events Associated with Balloon Sinuplasty: A MAUDE Database Analysis
    Hur, Kevin
    Ge, Marshall
    Kim, Jeehong
    Ference, Elisabeth H.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2020, 162 (01) : 137 - 141
  • [48] The real-world analysis of adverse events with teduglutide: a pharmacovigilance study based on the FAERS database
    Wang, Xiaogan
    Chen, Hao
    Han, Shuangshuang
    Li, Lingbo
    Chen, Hongjin
    Yang, Bolin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [49] Ocular Adverse Drug Events: Analysis of Spontaneous Reports from a Portuguese Regional Pharmacovigilance Database
    Penedones, A.
    Mendes, D.
    Alves, C.
    Batel-Marques, F.
    DRUG SAFETY, 2015, 38 (10) : 1006 - 1007
  • [50] Abrocitinib-associated adverse events: a real-world pharmacovigilance study using the FAERS database
    Sun, Yu
    Xu, Tao
    Zhu, Suyan
    Xu, Hongbin
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (02) : 233 - 239
12345